Learn More


 
MBA Tools
MBA Glossary

 


Myriad Genetics, Inc. - MYGN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Myriad Genetics, Inc. - SIC # 2835

Ticker Exchange SIC # Website Latest Ticker
MYGN Nasdaq 2835 http://www.myriad.com 32.93 Stock Down -0.20

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Myriad Genetics, Inc.

CE Mark for STJ's ILUMIEN OPTIS - May 17th, 2013 11:20 am
Stryker Reiterated at Neutral - May 17th, 2013 10:20 am
SGEN's Adcetris under FDA Review - May 16th, 2013 1:30 pm
Covidien Prices Senior Notes - May 16th, 2013 6:40 am
Much Awaited Test Launch by Genomic - May 15th, 2013 12:30 pm
Myriad Soars Higher on Celeb Clout - May 15th, 2013 12:00 pm
MYRIAD GENETICS INC Financials - May 15th, 2013 11:04 am
Myriad trade expects sharp move - May 15th, 2013 1:14 am


View All Current Headlines >>

Bookmark and Share
facebooktwitter